Burcu Çakar

767 total citations
49 papers, 434 citations indexed

About

Burcu Çakar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Burcu Çakar has authored 49 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Burcu Çakar's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Cancer Treatment Studies (6 papers). Burcu Çakar is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Cancer Treatment Studies (6 papers). Burcu Çakar collaborates with scholars based in Türkiye, United States and India. Burcu Çakar's co-authors include X. Cynthia, Rüçhan Uslu, Burçak Karaca, Bülent Karabulut, İdris Yücel, Mehmet Turgut, Dilek Erdem, Güzin Gönüllü, Umut Varol and Levent Altıntop and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal Of Pathology.

In The Last Decade

Burcu Çakar

40 papers receiving 421 citations

Peers

Burcu Çakar
Valentina Sini Italy
Mingfang Xu China
Khaled Murshed Qatar
Kriti Mittal United States
Yvonne Teng Singapore
J Mansi United Kingdom
Junxia Yao China
Anne K. Mylin Denmark
Sophie Barrett United Kingdom
Gaosheng Huang China
Valentina Sini Italy
Burcu Çakar
Citations per year, relative to Burcu Çakar Burcu Çakar (= 1×) peers Valentina Sini

Countries citing papers authored by Burcu Çakar

Since Specialization
Citations

This map shows the geographic impact of Burcu Çakar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burcu Çakar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burcu Çakar more than expected).

Fields of papers citing papers by Burcu Çakar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burcu Çakar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burcu Çakar. The network helps show where Burcu Çakar may publish in the future.

Co-authorship network of co-authors of Burcu Çakar

This figure shows the co-authorship network connecting the top 25 collaborators of Burcu Çakar. A scholar is included among the top collaborators of Burcu Çakar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burcu Çakar. Burcu Çakar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sezak, Murat, et al.. (2024). MCL-019 Synchronous CD5 (-) Mantle Cell Lymphoma and Gastric Adenocarcinoma: A case report. Clinical Lymphoma Myeloma & Leukemia. 24. S510–S510.
2.
Aksoy, Sercan, Burcu Çakar, Gül Başaran, et al.. (2023). Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group. Cancers. 15(6). 1667–1667. 1 indexed citations
3.
4.
Şendur, Mehmet Alı Nahıt, Burcu Çakar, Sercan Aksoy, et al.. (2021). 124P Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey. Annals of Oncology. 32. S74–S74. 1 indexed citations
5.
6.
Çakar, Burcu, et al.. (2021). Predictive role of neutropenia under crizotinib treatment in ALK-rearranged nonsmall cell lung cancer patients. Indian Journal of Cancer. 59(2). 251–256. 1 indexed citations
7.
Müftüler, Fazilet Zümrüt Biber, Emin İlker Medine, Özge Kozguş Güldü, et al.. (2020). Thymoquinone Glucuronide Conjugated Magnetic Nanoparticle for Bimodal Imaging and Treatment of Cancer as a Novel Theranostic Platform. Current Radiopharmaceuticals. 14(1). 23–36. 5 indexed citations
8.
Çakar, Burcu, et al.. (2019). Adrenocortical cancer: Single center experience. DergiPark (Istanbul University). 1 indexed citations
9.
Haydaroğlu, Ayfer, Burcu Çakar, Erhan Gökmen, et al.. (2019). Ege Üniversitesi Hastanesi veri tabanında meme kanseri hastalarının epidemiyolojisi ve genel sağ kalım özellikleri. Ege Tıp Dergisi. 50–57.
10.
Çakar, Burcu, Erhan Gökmen, Banu Sarsık, et al.. (2019). Ege Üniversitesi Hastanesinde testis kanserlerinin epidemiyolojisi ve genel sağ kalım özellikleri. Ege Tıp Dergisi. 126–132. 1 indexed citations
11.
Korkut, Mustafa, Ahmet Ömer Özütemiz, Başak Doğanavşargıl, et al.. (2019). Ege Üniversitesi Tıp Fakültesi veri tabanındaki kolorektal kanserli olguların epidemiyolojik ve genel sağ kalım özellikleri. Ege Tıp Dergisi. 68–77. 1 indexed citations
12.
Çakar, Burcu & Ulus Ali Şanlı. (2018). Kolorektal Kanserlerde Prognostik Faktörler. 11(4). 52–57. 1 indexed citations
13.
Çakar, Burcu, et al.. (2018). The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome. SHILAP Revista de lepidopterología. 14(4). 211–217. 15 indexed citations
14.
Çakar, Burcu, Atike Pınar Erdoğan, Raika Durusoy, et al.. (2015). The Role of Body Mass Index in Triple Negative Breast Cancer. Oncology Research and Treatment. 38(10). 518–522. 12 indexed citations
15.
Varol, Umut, Burcu Çakar, Çağatay Arslan, et al.. (2015). Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment in patients with metastatic breast cancer. Oncology Letters. 10(4). 2598–2602. 11 indexed citations
16.
Varol, Umut, Burcu Çakar, İbrahim Yıldız, et al.. (2014). Survival Analysis of Triple Negative and Her2 Positive Breast Cancer Patients: Single Center Report. SHILAP Revista de lepidopterología. 10(1). 42–46. 1 indexed citations
17.
Çakar, Burcu, et al.. (2013). Targeted Therapy for Breast Cancer. American Journal Of Pathology. 183(4). 1096–1112. 105 indexed citations
18.
Sarsık, Banu, et al.. (2013). Predictive and prognostic values of Tau and BubR1 protein in prostate cancer and their relationship to the Gleason score. Medical Oncology. 30(2). 526–526. 17 indexed citations
19.
Kısım, Aslı, Harika Atmaca, Burcu Çakar, et al.. (2012). Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels. Journal of Cancer Research and Clinical Oncology. 138(7). 1155–1163. 21 indexed citations
20.
Varol, Umut, Burçak Karaca, Burcu Çakar, et al.. (2012). Comparing Time to Disease Progression of Irinotecan and Oxaliplatin-based Chemotherapies in Colorectal Cancer Patients With Liver Only Metastasis. American Journal of Clinical Oncology. 36(4). 388–391. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valentina Sini Breakdown of academic impact, for papers by Mingfang Xu Breakdown of academic impact, for papers by Khaled Murshed Breakdown of academic impact, for papers by Kriti Mittal Breakdown of academic impact, for papers by Yvonne Teng Breakdown of academic impact, for papers by J Mansi Breakdown of academic impact, for papers by Junxia Yao Breakdown of academic impact, for papers by Anne K. Mylin Breakdown of academic impact, for papers by Sophie Barrett Breakdown of academic impact, for papers by Gaosheng Huang
Rankless by CCL
2026